North East and North Cumbria
ICS Formulary
ICS Formulary
6 Endocrine system
06-07-04 Somatomedins
| Mecasermin Increlex® |
|
Formulary
|
 MHRA Drug Safety Update (Jan 2020): Mecasermin (Increlex▼): risk of benign and malignant neoplasia |
|
Links